v3.26.1
Nature of Business and Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Dec. 05, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Sep. 30, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Antidilutive securities earning per share   105,058,166 108,823,464 105,058,166 108,823,464  
Conversion of preferred shares       8,340,000    
Other fees $ 69,000 $ 253,556   $ 253,556    
Deferred offering costs       $ 255,853
Series A Convertible Preferred Stock [Member]            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Conversion of preferred shares   13,579,710 13,579,710 13,579,710 13,579,710  
Series B Convertible Preferred Stock [Member]            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Conversion of preferred shares   13,579,710 13,579,710 13,579,710 13,579,710  
Share-Based Payment Arrangement, Option [Member]            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Antidilutive securities earning per share   7,920,000 8,120,000 7,920,000 8,120,000  
Warrant [Member]            
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]            
Antidilutive securities earning per share   18,087,363 15,387,050 18,087,363 15,387,050